dc.contributor |
Universitat de Barcelona |
dc.contributor.author |
Mas-Expósito, Laia |
dc.contributor.author |
Amador, Juan Antonio |
dc.contributor.author |
Gómez Benito, Juana |
dc.contributor.author |
Lalucat-Jo, Lluís |
dc.date |
2018-10-22T13:28:58Z |
dc.date |
2018-10-22T13:28:58Z |
dc.date |
2012 |
dc.date |
2018-10-22T13:28:58Z |
dc.identifier.citation |
0010-440X |
dc.identifier.citation |
601112 |
dc.identifier.uri |
http://hdl.handle.net/2445/125490 |
dc.format |
32 p. |
dc.format |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Elsevier B.V. |
dc.relation |
Versió postprint del document publicat a: https://doi.org/10.1016/j.comppsych.2011.02.009 |
dc.relation |
Comprehensive Psychiatry, 2012, vol. 53, num. 2, p. 208-216 |
dc.relation |
https://doi.org/10.1016/j.comppsych.2011.02.009 |
dc.rights |
(c) Elsevier B.V., 2012 |
dc.rights |
info:eu-repo/semantics/openAccess |
dc.subject |
Esquizofrènia |
dc.subject |
Psicometria |
dc.subject |
Escales d'avaluació psiquiàtrica |
dc.subject |
Schizophrenia |
dc.subject |
Psychometrics |
dc.subject |
Psychiatric rating scales |
dc.title |
The World Health Organization Short Disability Assessment Schedule: a validation study in patiens with schizophrenia |
dc.type |
info:eu-repo/semantics/article |
dc.type |
info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |
Purpose: The World Health Organization Short Disability Assessment Schedule (DAS-s) is used for patients with schizophrenia even though no validation is available. This paper addresses this issue by dealing with its psychometric properties in a clinical sample of patients with schizophrenia. Methods: Two hundred forty-one patients from 10 Adult Mental Health Care Centres (AMHCC) meeting the following inclusion criteria were included: 1) International Classification of Diseases-10 or ICD-10 diagnosis o schizophrenia; 2) Global Assessment of Functioning scores or GAF ≤50; 3) Illness duration of more than 2 years; and 4) Clinical stability at assessment time. Patients were evaluated at baseline and at one-year follow-up regarding disability, socio-demographic and clinical variables, psychosocial measures and use of mental health services. Results: The factor analysis revealed a single factor that explained 60.57% of the variance. Internal consistency values were appropriate for the DAS-s total (0.78 at baseline and 0.78 at one year follow-up). Correlations between DAS-s scores and those of global functioning, psychiatric symptoms, social support and quality of life ranged between small and moderate (range: 0.13-0.39). There were significant differences between groups of patients with schizophrenia in the DAS-s. Patients who were unemployed, with lower global functioning, with cognitive impairment and lacking social support scored significantly lower in DAS-s scores. After one year follow-up, there was a non-significant decrease in DAS-s scores and patients improved significantly in overall functioning and psychiatric symptoms. Discussion: This study shows that the DAS-s has good reliability and validity, and suggests that it is suitable for the assessment of disability in patients with schizophrenia. |